2011

November 10, 2011- BioMarker Strategies and The Wistar Institute presented data from their pre-clinical collaboration at the 2011 International Melanoma Congress, demonstrating the utility of the SnapPath™ platform in generating phosphoprotein-based FSPs. Press Release

September 28, 2011- BioMarker Strategies awarded NCI SBIR contract to develop companion diagnostic test, raises $2.3M in investments Press Release

Press Coverage:
Genetic Engineering & Biotechnology News
Genomeweb

June 2011- BioMarker Strategies highlighted in In Vivo June 2011. Read Article

May 27, 2011- BioMarker Strategies names Glenn Miller, PhD, Chairman of Board, and Dr. Douglas P. Clark, CMO/Acting CEO (Effective July 1). Press Release

April 5, 2011- BioMarker Strategies presented an abstract, titled Functional Stratification of Breast Carcinoma Cells Enables Predictive Therapeutic Strategies, at the 2011 AACR Annual Meeting. Read Abstract | View Poster

March 31, 2011- BioMarker Strategies received $1M in Year 2 funding from the NCI for its Phase II SBIR contract.

March 2011- BioMarker Strategies profiled in Clinica Medtech Intelligence magazine as the "Hot pick of the month". Read Article

February 2011- BioMarker Strategies spotlighted in Frost & Sullivan's twice-monthly feature on the latest in Healthcare industry strategy and advice. Read Article Summary

January 2011- BioMarker Strategies expands its Board of Directors, welcoming Dr. Samuel Broder, Dr. Mark Velleca, and Dr. Paul Beresford. Read Article

Please send media inquiries to info@biomarkerstrategies.com or you can contact Scott Allocco at 410-522-1008.